Related Experiment Video
Updated: Feb 28, 2026

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
Published on: June 6, 2025
Intensive BP Control and Cognitive Function: A Randomized Clinical Trial
Bin Wang1,2, Ying Sun1, Yan Li1
1National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Center for Cardiovascular Diseases, Beijing, China (B.W., Y.S., Y. Li, Y.P., S.L., J.G., L. Zhang, L. Zhao, Jiangling Liu, H.Z., Jiamin Liu, Jing Li).
Insights
Intensive blood pressure control in Chinese adults did not negatively impact cognitive function. This study confirms the cognitive safety of targeting lower systolic blood pressure (<120 mm Hg) in hypertensive individuals.
Area of Science:
- Cardiology
- Neurology
- Gerontology
Background:
- Uncertainty exists regarding intensive blood pressure (BP) control effects on cognition in East Asians.
- Hypertension management strategies require evaluation for cognitive impact.
Purpose of the Study:
- To assess the effect of intensive systolic BP target (<120 mm Hg) versus standard target (<140 mm Hg) on global cognitive function.
- To evaluate cognitive safety of intensive BP lowering in Chinese hypertensive adults.
Main Methods:
- Secondary analysis of a randomized trial in 11,255 Chinese hypertensive adults with high cardiovascular risk.
- Cognitive function assessed using Mini-Mental State Examination (MMSE) at baseline and after a median of 3.4 years.
- Primary outcomes: change in MMSE score and probable dementia incidence.
Main Results:
- No significant difference in mean MMSE score change between intensive (-0.54) and standard (-0.60) BP arms.
- Results were consistent across sensitivity analyses and most subgroups.
- Probable dementia incidence was too low for interpretation.
Conclusions:
- Intensive systolic BP lowering to <120 mm Hg for 3 years did not adversely affect global cognitive function in Chinese hypertensive adults.
- The findings affirm the cognitive safety of intensive BP control strategies.
- Cognitive effects were consistent across various demographics and comorbidities.
Background:
The impact of intensive blood pressure (BP) control on cognitive function in East Asian populations remains uncertain. We aimed to assess the effect of a lower systolic BP target on global cognitive function in Chinese hypertensive adults.
Methods:
This secondary analysis of a randomized trial involved hypertensive patients with high cardiovascular risk across 116 sites in China. Participants were assigned to receive intensive treatment (systolic BP target <120 mm Hg) or standard treatment (systolic BP target <140 mm Hg) for a median of 3.4 years. Cognitive function was assessed via MMSE (Mini-Mental State Examination) at baseline and the end of the study. Prespecified outcomes were a change in MMSE score and investigator-reported probable dementia.
Results:
Among 11 255 randomized participants, all completed cognitive assessment at baseline and 10 440 (92.8%) at the end of the study. The mean change in MMSE score was not significantly different between arms (difference, 0.05 [95% CI, -0.07 to 0.17]), with a mean change of -0.54 (95% CI, -0.63 to -0.46) in the intensive arm and -0.60 (95% CI, -0.68 to -0.51) in the standard arm. Results were robust across sensitivity analyses and consistent across most subgroups. Exceptions included subgroups of coronary heart disease or antiplatelet treatment. The incidence of probable dementia was too low for meaningful interpretation.
Conclusions:
Intensive systolic BP lowering to a target of <120 mm Hg for 3 years did not adversely affect global cognitive function in Chinese hypertensive adults, irrespective of age, sex, BP level, and comorbidities, affirming the cognitive safety of this treatment strategy.
Registration:
URL: https://www.clinicaltrials.gov; Unique identifier: NCT04030234.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension and Regulation of Blood Pressure
Neural Regulation of Blood Pressure
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Hypertension V: Nursing Management
Hypertension II: Pathophysiology
